Company intelligence / Profile preview

Circle Labs Bio

Massachusetts, United Statesfullcirclelabs.bio ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Circle Labs Bio uses artificial intelligence/machine learning-driven tools to rapidly manufacture high-quality RNA—primarily mRNA—to accelerate biological research. Their technology enables faster experimental iteration in drug discovery by delivering optimized sequences 3–6 times faster than industry standards. They serve as an enabling partner for biopharma companies developing RNA medicines but do not themselves report clinical results or proprietary therapeutic programs[1][2][5].

Modalities: mRNA-based drugsRNA therapy
Industry: Drug Discovery Services

Partnerships

Not specifically listed, but the company states it partners with "top teams across biopharma"

Beyond the preview

Go deeper on Circle Labs Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circle Labs Bio.

Explore the full profile